Tirzepatide is an innovative dual GIP/GLP-1 receptor agonist. This medication has shown exceptional results in clinical trials for the treatment of type 2 diabetes. By activating both the GIP and GLP-1 receptors, https://deannaqaim227144.blog-gold.com/57295865/tirzepatide-a-novel-dual-gip-glp-1-receptor-agonist